Join us in Roosevelt Hotel between 11th – 13th February where we’ll be sharing the latest insights and innovations from the EntityRisk team on industry hot topics including value assessment, pricing strategies, and evidence generation in today’s evolving pharma landscape.
EntityRisk integrates globally renowned health economics and policy expertise with PROVEN™, our advanced modelling software, to predict health outcomes, identify maximum value-based pricing, and substantiate evidence-generation investments.
10 of the Top 20 Biopharma Companies work with EntityRisk to navigate the shifting policy landscape and confidently choose and defend justifiable prices, inform evidence investments, and communicate and win on value.
Top Biopharma Companies
Quality Checks
ML Modules